Modulation of anti-apoptosis by endogenous IAP expression in MKN45 human gastric cancer cells

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2713-2718

  Endo, Kazuya ^a   Kohnoe, Shunji ^a   Tsujita, Eiji ^a   Watanabe, Akihiro ^a   Nakashima, Hideaki ^a   Baba, Hideo ^b   Maehara, Yoshihiko ^b  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti apoptosis; Gastric cancer cell; IAP; Inhibitor of apoptosis protein

Indexed keywords

CASPASE 3; CISPLATIN; CYTOCHROME C; DNA FRAGMENT; INHIBITOR OF APOPTOSIS PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C DELTA; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOSOL; DNA CONFORMATION; DRUG SENSITIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKEMIA CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STOMACH CANCER;

APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CISPLATIN; CYTOCHROMES C; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEINS; STOMACH NEOPLASMS; U937 CELLS;

EID: 22944479004     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Endo K, Maehara Y, Kusumoto T et al: Expression of multidrug-resistance- associated protein (MRP) and chemo- sensitivity in human gastric cancer. Int J Cancer 68: 372-377, 1996.
2. Cole SPC, Bhardwaj G, Gerlach JH et al: Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science (Wash. DC) 258: 1650-1654, 1992.
3. Pastan I and Gottesman MM: Multidrug resistance in human cancer. N Engl J Med 316: 1388-1393, 1987.
4. Croop J, Gros P and Housman DE: Genetics of multidrug resistance. J Clin Invest 81: 1303-1309, 1988.
5. Li P, Nijhawan D, Budihardjo I et al: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
6. Kojima H, Endo K, Moriyama H et al: Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 25: 16647-16650, 1998.
7. Zou H, Henzel WJ, Liu X et al: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997.
8. Yang J, Liu X, Bhalla K et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
9. Kluck RM, Bossy-Wetzel E, Green DR et al: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
10. Kharbanda S, Pandey P, Schofield L et al: Role for Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci USA 94: 6939-6942, 1997.
11. Kondo S, Shinomura Y, Kanayama S et al: Modulation of apoptosis by endogenous Bcl-xL expression in MKN45 human gastric cancer cells. Oncogene 17: 2585-2591, 1998.
12. Deveraux Q, Roy N, Stennicke H et al: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17: 2215-2223, 1998.
13. Deveraux Q, Takahashi R, Salvesen G et al: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304, 1997.
14. Roy N, Deveraux Q, Takahashi R et al: The cIAP1 and cIAP2 proteins are distinct inhibitors of specific caspases. EMBO J 16: 6914-6925, 1997.
15. Wang CY, Mayo MW, Korneluk RG et al: NF-kB antiapoptosis: induction of TRAF1 and TRAF2 and cIAP1 and cIAP2 to suppress caspase-8 activation. Science (Wash. DC) 281: 1680-1683, 1998.
16. Tamm I, Wang Y, Sausville E, Scudiero DA et al: IAP -family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases and anticancer drugs. Cancer Res 58: 5315-5320, 1998.
17. Sanna MG, Duckett CS, Richter BW et al: Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc Natl Acad Sci USA 95: 6015-6020, 1998.
18. Drucker BJ, Talpaz M, Resta D et al: Clinical efficacy and safety of an Abl specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia. Blood 9: 368a, 1999.
19. Lowenberg B, Downing JR and Burnett A: Acute myeloid leukemia. N Engl J Med 341: 1051-1062, 1999.
20. Desnoyers S, Shah GM, Brochu G et al: Erasable blot of poly(ADP-ribose) polymerase. Ann Biochem 218: 470-473, 1994.
21. Datta R, Banach D, Kojima H et al: Activation of the CPP32 protease in apoptosis induced hy 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88: 1936-1943, 1996.
22. Datta R, Kojima H, Banach D et al: Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J Biol Chem 272: 1965-1969, 1997.
23. Sakahira H, Enari M and Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99, 1998.
24. Enari M, Sakahira H, Yokoyama H et al: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50, 1998.
25. Kusumoto T, Maehara Y, Sakaguchi Y et al: Tissue distribution of cis-diamminedichloroplatinum (II) following intraperitoneal administration to patients with recurrent gastric cancer. Oncology 50: 214-217, 1993.
26. Chung Y-S, Yamashita Y, Inoue T et al: Continous infusion of 5-fluouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80: 1-7, 1997.
27. Johnsson A, Oisson C, Anderson H et al: Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissue from nude mice. Cytometry 17: 142-150, 1994.
28. Liu X, Naekyung Kim C, Yang J et al: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.
29. Datta R, Kojima H, Yoshida K et al: Caspase-3-mediated cleavage of protein kinase c θ in induction of apoptosis. J Biol Chem 272: 20317-20320, 1997.
30. Ghayur T, Hugunin M, Talanian RV et al: Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184: 2399-2404, 1996.
31. Yang L-Q, Fang D-C, Wang R-Q and Yang S-M: Effect of NF-kB, survivin, Bcl-2 and caspase 3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol 10: 22-25, 2004.
32. Datta R, Manome Y, Taneja N et al: Overexpression of Bcl-xL by cytotoxic drug exposure confers resistance to ionizing induced internucleosomal DNA fragmentation. Cell Growth Differ 6(4): 363-370, 1995.
33. Nakamura M, Tsuji N, Asanuma K et al: Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients. Cancer Sci 95: 44-51, 2004.
34. Yu J, Leung WK, Ebert MPA et al: Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 87: 91-97, 2002.
35. Byun D-S, Cho K, Ryu B-K et al: Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinoma. Cancer Res 63: 7068-7075, 2003.
36. Tu SP, Jiang XH, Lin MCM et al: Suppression of survivin expression inhibits in vivo tumorgenicity and angiogenesis in gastric cancer. Cancer Res 63: 7724-7732, 2003.